PRAMEF6 Activators
PRAMEF6, short for PRAME Family Member 6, is a gene that encodes a protein belonging to the PRAME (Preferentially Expressed Antigen in Melanoma) family of genes. This family is characterized by genes that are typically expressed in a limited fashion within healthy tissues but show elevated levels of expression in certain types of cancer cells. The proteins encoded by PRAME family members are speculated to play roles in the normal governance of cellular processes, such as cell cycle regulation and immune surveillance. PRAMEF6, like others in its family, has drawn scientific interest due to its distinctive expression pattern, which may serve as an insightful indicator of complex biological processes. The precise biological functions of PRAMEF6 remain an active area of research, with ongoing studies aiming to elucidate its role in cellular physiology and the mechanisms governing its expression.
The expression of PRAMEF6 can potentially be induced by a variety of chemical compounds known as activators. These activators are diverse in structure and function, and they are capable of initiating a series of cellular events that lead to the upregulation of gene expression. For example, compounds like 5-Aza-2'-deoxycytidine and Trichostatin A are known to alter the epigenetic landscape of cells, potentially removing molecular 'brakes' that suppress gene expression, thereby allowing genes such as PRAMEF6 to be transcribed. Other compounds, such as retinoic acid and beta-estradiol, interact with specific receptors within the cell to initiate a cascade of transcriptional events, culminating in the upsurge of target gene expression. Forskolin and TPA (12-O-Tetradecanoylphorbol-13-acetate) operate through the activation of intracellular enzymes that modulate transcription factors, which can lead to the enhanced transcription of genes. These activators, along with others like sodium butyrate, lithium chloride, and natural compounds such as epigallocatechin gallate, curcumin, and Vitamin D3, are known to interact with cellular pathways in ways that could potentially lead to the increased expression of PRAMEF6. These interactions offer valuable insights into the underlying principles of gene regulation and cellular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This DNA methyltransferase inhibitor may demethylate gene promoters, potentially leading to the reactivation of silenced genes, which could upregulate PRAMEF6 transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A could unravel chromatin structure to allow transcriptional machinery access to DNA, potentially resulting in increased PRAMEF6 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
By binding to retinoic acid receptors, retinoic acid may initiate transcriptional cascades that stimulate the expression of genes involved in differentiation, possibly including PRAMEF6. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This estrogen may bind to estrogen receptors, triggering a signal transduction pathway that could stimulate the transcription of target genes, potentially leading to an upsurge in PRAMEF6 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating intracellular cAMP, forskolin can activate PKA, leading to the activation of transcription factors that could stimulate PRAMEF6 gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
This glucocorticoid may activate glucocorticoid receptors, initiating a transcriptional response that could include the upregulation of PRAMEF6 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate PKC, which may lead to a cascade of events culminating in the activation of transcription factors and a consequent surge in PRAMEF6 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, by inhibiting histone deacetylase, could induce a more accessible chromatin state, leading to the upregulation of several genes, potentially including PRAMEF6. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3, leading to increased β-catenin levels, which may enter the nucleus and stimulate the transcription of Wnt target genes, potentially including PRAMEF6. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin may inhibit DNA methyltransferases, potentially leading to the demethylation and subsequent upregulation of certain genes, including potentially PRAMEF6. | ||||||